Vendor · VERIFIED · Updated 2026-04-22

BioLongevity Labs

USA · biolongevitylabs.com

VERIFIED Active
Tier
V
Third-party tested · COAs publicly posted
Third-party testing
Yes
Triple third-party testing
Public COAs
Yes
Available on product pages
Catalog
32
known compounds
Visit BioLongevity Labs →
Code VIALBASE at checkout
Testing & verification
Third-party tested
Yes
COA publicly posted
Yes
Method
Triple third-party testing
Shipping
  • Domestic
  • Cold chain
Payment
  • Credit Card
  • Crypto
Community signal
Reddit sentiment
positive
Finnrick tested
No

What they carry

BioLongevity Labs

US-based vendor with a focus on longevity peptides. Distinguishes itself through triple third-party testing — each batch tested by three independent labs.

Overview

BioLongevity Labs positions itself in the longevity and anti-aging peptide niche. Their key differentiator is triple third-party testing — they claim each batch is tested by three separate independent laboratories, providing an extra layer of quality assurance beyond the single-lab testing standard in the industry. This approach is rare and notable.

Products & Testing

Longevity-focused product line including BPC-157, TB-500, GHK-Cu, Epithalon, and NAD+. The triple testing protocol is their standout feature — each batch is reportedly verified by three independent labs. Specific lab partners are not publicly disclosed (needs verification). COAs are publicly available.

The triple-testing claim should be verified independently. If legitimate, this represents the highest testing standard among US peptide vendors.

Shipping & Payment

  • Domestic: Yes (US)
  • International: Unknown — needs verification
  • Cold chain: Yes (assumed based on standard practice)
  • Payment: Credit Card, Crypto (needs verification)

Community Reputation

Reddit sentiment is generally positive. Not yet tested by Finnrick. The triple-testing claim generates interest in the community. Relatively newer vendor compared to established Tier 1 names. Community reviews should be monitored.

Regulatory Status

No FDA warnings or enforcement actions as of April 2026. Clean regulatory record.

Compounds Available